Theme & Objectives

The joint Congress of the International Osteoporosis Foundation and the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis is a unique opportunity for clinicians and researchers from around the world to participate in the premiere meeting of 2010 in the field of osteoporosis and osteoarthritis. The Congress will offer an overview of the most recent developments and cutting-edge research in the pathophysiology, diagnosis, prevention and treatment of osteoporosis and osteoarthritis, as well as policy-related issues such as health economics. The Congress also provides a forum for stimulating interaction, not just for research specialists, but also for practitioners and other health professionals who can profit from the exchange of information provided in numerous Meet-The-Expert sessions.
 

Target Audience

The scope of the Congress covers all aspects of osteoporosis and related bone diseases. Participants will include rheumatologists, gynaecologists, endocrinologists, internal medicine specialists, orthopaedic surgeons, radiologists, nurses, rehabilitation professionals, public health personnel, epidemiologists, pharmacists, and pharmaceutical industry representatives.
 

Plenary Sessions

There will be twelve plenary lectures. Each session will be dedicated to a single theme and will feature an invited speaker along with oral communications selected from submitted abstracts. The following topics and respective speakers are planned and confirmed:

• Cellular Control of Bone Mass - R. Baron (USA)
• Oseoporosis and Biological Aging - S. R. Cummings (USA)
• Why do bones break? Contributions of cortical and cancellous bone to whole bone strength - M. L. Bouxsein (USA)
• OLOF JOHNELL MEMORIAL LECTURE: Do Men and Women Fracture at the Same BMD? - J.A. Kanis (UK)
• Region Specific Fracture Risk and Response to Therapy - E. Seeman (Australia)
• What Did We Learn from Genome-wide Association Studies? - T. Spector (UK)
• Interaction Between Bone and Joints in Physiology and Disease - G. Schett (Germany)
• Glitazone and Bone: A paradigm to better understand bone physiology - C. J. Rosen (USA)
• Extra Skeletal Effects of Vitamin D - B. Dawson-Hughes (USA)
• Stimulators/inhibitors of Bone Turnover, Together or One After the Other - J.P. Bilezikian (USA)
• Developmental Plasticity and Later Osteoporosis - M. A. Hanson (UK)
• Emerging Therapies - S. E. Papapoulos (NL)

Poster Sessions

All submitted abstracts not scheduled for oral presentation will be eligible for poster presentation.

Meet-The-Expert Sessions

Each day specialists will lead exchanges on 19 key topics. Small groups, on a first come first served basis, will be encouraged to not only ask questions but to also provide feedback about their own experiences. The following topics and respective speakers are planned and confirmed:

• Assessing Bone Strength Beyond DXA - C. Glueer (Germany)
• Optimal Dose of Vitamin D - B. Dawson-Hughes (USA)
• Muscle and Bone Interaction - D. Felsenberg (Germany)
• Practical Approach of Glucocorticoid-treated Patients - J. Adachi (Canada)
• Health Economics and Treatment Selection - J.Y. Reginster and Oliver Bruyère (Belgium)
• BMU Balance: Effects of antiosteoporotic agents - J. Compston (UK)
• Premenopausal Osteoporosis - U. Liberman (Israel)
• Fracture Healing: Can we nfluence it? - J. Goldhahn (Switzerland)
• Bone Disease in Primary Hyperparathyroidism - J.P. Bilezikian (USA)
• Bisphosphonates in Chronic Renal Failure - S. E. Papapoulos (NL)
• Pharmaco-genomics - M.L. Brandi (Italy)
• Vertebro/kyphoplasty - S. Boonen (Belgium)
• Issues in Designing and Conducting Clinical Trials - S. R. Cummings (USA)
• Osteoporosis in Men - E. Seeman (Australia)
• Post-fracture Management - K. Akesson (Sweden)
• Genetics and Osteoporosis: How to assess it? - S. Ferrari (Switzerland)
• Side Effects of Anti Fracture Drugs - S. Adami (Italy)
• Epidemiological Aspects of Osteoporosis - C. Cooper (UK)
• Gait and Falls - T. Masud (UK)